Perimeter Medical Imaging AI, Inc.
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 846,194 | 403,533 | 132,766 | 9,000 |
| Operating Revenue | 846,194 | 403,533 | 132,766 | 9,000 |
| Cost Of Revenue | 311,084 | 197,114 | 136,095 | 5,000 |
| Gross Profit | 535,110 | 206,419 | -3,329 | 4,000 |
| Selling General And Administration | 12.2M | 11.1M | 10.3M | 9.2M |
| General And Administrative Expense | 6.8M | 6.1M | 5.4M | 6.3M |
| Research And Development | 6.6M | 5.2M | 5.5M | 3.6M |
| Depreciation And Amortization In Income Statement | 510,295 | 471,545 | 696,908 | 74,799 |
| Other Operating Expenses | -144,775 | -241,221 | -337,189 | -72,013 |
| Operating Expense | 19.2M | 16.5M | 16.1M | 12.8M |
| Operating Income | -18.7M | -16.3M | -16.1M | -12.8M |
| EBIT | -13.4M | -13.9M | -9.8M | -13.2M |
| Interest Expense | 26,088 | 144,443 | 103,756 | 88,108 |
| Interest Expense Non Operating | 26,088 | 144,443 | 103,756 | 88,108 |
| Interest Income | -- | -- | -- | 7,836 |
| Interest Income Non Operating | -- | -- | -- | 7,836 |
| Net Interest Income | 272,857 | 581,132 | -104,932 | -80,272 |
| Other Income Expense | 5.0M | 1.6M | 6.3M | -383,428 |
| Special Income Charges | -- | -- | -- | 0.00 |
| Restructuring And Mergern Acquisition | -- | -- | -- | 0.00 |
| Gain On Sale Of Security | 5.0M | 1.6M | 6.3M | -383,428 |
| Pretax Income | -13.4M | -14.0M | -9.9M | -13.3M |
| Tax Provision | -- | -- | 0.00 | 0.00 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Income From Continuing Operation Net Minority Interest | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Income Including Noncontrolling Interests | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Income Common Stockholders | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Income | -13.4M | -14.0M | -9.9M | -13.3M |
| EBITDA | -12.6M | -13.3M | -9.0M | -13.1M |
| Normalized EBITDA | -17.7M | -14.9M | -15.3M | -12.7M |
| Reconciled Depreciation | 729,668 | 614,704 | 800,864 | 74,799 |
| Basic EPS | -0.19 | -0.22 | -0.16 | -0.30 |
| Diluted EPS | -0.19 | -0.22 | -0.16 | -0.30 |
| Basic Average Shares | 71.5M | 64.7M | 60.6M | 44.1M |
| Diluted Average Shares | 71.5M | 64.7M | 60.6M | 44.1M |
| Total Unusual Items | 5.0M | 1.6M | 6.3M | -383,428 |
| Total Unusual Items Excluding Goodwill | 5.0M | 1.6M | 6.3M | -383,428 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -18.4M | -15.7M | -16.2M | -12.9M |
| Depreciation Amortization Depletion Income Statement | 510,295 | 471,545 | 696,908 | 74,799 |
| Depreciation Income Statement | 510,295 | 471,545 | 696,908 | 74,799 |
| Diluted NI Availto Com Stockholders | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Income Continuous Operations | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Non Operating Interest Income Expense | 272,857 | 581,132 | -104,932 | -80,272 |
| Other Gand A | 6.8M | 6.1M | 5.4M | 6.3M |
| Reconciled Cost Of Revenue | 91,711 | 53,955 | 32,139 | 5,000 |
| Selling And Marketing Expense | 5.4M | 5.0M | 4.8M | 2.9M |
| Total Expenses | 19.6M | 16.7M | 16.3M | 12.8M |
| Total Other Finance Cost | -298,945 | -725,575 | 1,176 | 427.44 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 6.2M | 14.0M | 28.4M | 3.7M |
| Cash Cash Equivalents And Short Term Investments | 6.2M | 14.0M | 28.4M | 4.1M |
| Cash Equivalents | -- | -- | 0.00 | 26,004 |
| Cash Financial | -- | -- | 28.4M | 3.7M |
| Other Short Term Investments | -- | -- | 0.00 | 333,315 |
| Accounts Receivable | 390,525 | 36,900 | 72,000 | 0.00 |
| Receivables | 2.4M | 2.3M | 2.0M | 1.1M |
| Inventory | 191,577 | 128,999 | 42,880 | 5,031 |
| Prepaid Assets | 1.2M | 1.1M | 1.0M | 987,615 |
| Current Assets | 10.0M | 17.6M | 31.5M | 6.1M |
| Gross PPE | 6.5M | 4.5M | 4.0M | 1.9M |
| Accumulated Depreciation | -2.1M | -1.5M | -882,722 | -147,479 |
| Net PPE | 4.4M | 3.0M | 3.1M | 1.8M |
| Goodwill And Other Intangible Assets | -- | -- | 0.00 | 1,460 |
| Other Non Current Assets | 1.00 | -- | -- | -- |
| Total Non Current Assets | 4.4M | 3.0M | 3.1M | 1.8M |
| Total Assets | 14.3M | 20.5M | 34.6M | 7.9M |
| Current Debt | -- | -- | 110,383 | 100,480 |
| Current Debt And Capital Lease Obligation | 46,813 | 50,565 | 150,157 | 142,288 |
| Payables And Accrued Expenses | 3.3M | 1.7M | 1.8M | 1.5M |
| Current Deferred Revenue | 144,226 | 49,032 | 103,724 | 88,831 |
| Other Current Liabilities | 53,182 | 3.5M | 6.0M | -- |
| Current Liabilities | 3.6M | 5.2M | 8.0M | 1.7M |
| Long Term Debt | -- | -- | 9,654 | 128,248 |
| Long Term Debt And Capital Lease Obligation | 90,671 | 142,329 | 175,519 | 205,699 |
| Long Term Capital Lease Obligation | 90,671 | 142,329 | 165,865 | 77,451 |
| Total Non Current Liabilities Net Minority Interest | 296,232 | 238,072 | 447,437 | 327,107 |
| Total Liabilities Net Minority Interest | 3.9M | 5.5M | 8.5M | 2.0M |
| Common Stock | 90.6M | 81.8M | 80.8M | 47.6M |
| Capital Stock | 90.6M | 81.8M | 80.8M | 47.6M |
| Additional Paid In Capital | 9.4M | 7.6M | 6.6M | 6.7M |
| Retained Earnings | -86.8M | -73.4M | -59.3M | -49.4M |
| Gains Losses Not Affecting Retained Earnings | -2.8M | -1.0M | -2.0M | 1.0M |
| Common Stock Equity | 10.5M | 15.1M | 26.1M | 5.9M |
| Stockholders Equity | 10.5M | 15.1M | 26.1M | 5.9M |
| Total Equity Gross Minority Interest | 10.5M | 15.1M | 26.1M | 5.9M |
| Total Capitalization | 10.5M | 15.1M | 26.1M | 6.0M |
| Net Tangible Assets | 10.5M | 15.1M | 26.1M | 5.9M |
| Tangible Book Value | 10.5M | 15.1M | 26.1M | 5.9M |
| Working Capital | 6.4M | 12.3M | 23.5M | 4.4M |
| Invested Capital | 10.5M | 15.1M | 26.2M | 6.1M |
| Total Debt | 137,484 | 192,894 | 325,676 | 347,987 |
| Share Issued | 93.5M | 65.1M | 64.5M | 45.3M |
| Ordinary Shares Number | 93.5M | 65.1M | 64.5M | 45.3M |
| Accrued Interest Receivable | 19,292 | 45,061 | 0.00 | -- |
| Capital Lease Obligations | 137,484 | 192,894 | 205,639 | 119,259 |
| Construction In Progress | 2.1M | 764,645 | 766,518 | 1.2M |
| Current Capital Lease Obligation | 46,813 | 50,565 | 39,774 | 41,808 |
| Current Deferred Liabilities | 144,226 | 49,032 | 103,724 | 88,831 |
| Foreign Currency Translation Adjustments | -2.8M | -1.0M | -2.0M | 1.0M |
| Leases | 145,594 | 147,456 | 124,189 | 92,774 |
| Machinery Furniture Equipment | 70,528 | 76,663 | 64,035 | 65,578 |
| Non Current Deferred Liabilities | 205,561 | 95,743 | 271,918 | 121,408 |
| Non Current Deferred Revenue | 205,561 | 95,743 | 271,918 | 121,408 |
| Other Current Borrowings | -- | -- | 110,383 | 100,480 |
| Other Properties | 4.2M | 3.5M | 3.0M | 519,066 |
| Other Receivables | 1.9M | 1.9M | 1.8M | 808,654 |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| Taxes Receivable | 52,297 | 321,776 | 152,623 | 243,712 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -14.7M | -14.7M | -11.9M | -10.9M |
| Cash Flow From Continuing Operating Activities | -14.7M | -14.7M | -11.9M | -10.9M |
| Depreciation And Amortization | 729,668 | 614,704 | 800,864 | 74,799 |
| Depreciation Amortization Depletion | 729,668 | 614,704 | 800,864 | 74,799 |
| Stock Based Compensation | 1.9M | 1.5M | 1.5M | 2.5M |
| Change In Working Capital | 1.8M | -569,260 | -226,281 | -793,187 |
| Changes In Account Receivables | -353,625 | 35,100 | -72,000 | 0.00 |
| Change In Receivables | -29,960 | -328,520 | -430,451 | -909,595 |
| Change In Inventory | -62,578 | -86,119 | -37,849 | -5,031 |
| Change In Payables And Accrued Expense | 1.6M | -70,324 | 291,476 | 507,584 |
| Change In Other Working Capital | -110,272 | -- | -- | -- |
| Other Non Cash Items | -417,632 | -822,353 | -2.5M | 477,774 |
| Capital Expenditure | -2.2M | -474,503 | -2.0M | -1.7M |
| Purchase Of PPE | -2.2M | -474,503 | -2.0M | -1.7M |
| Net PPE Purchase And Sale | -2.2M | -474,503 | -2.0M | -1.7M |
| Sale Of Business | -- | -- | -- | 0.00 |
| Sale Of Investment | -- | 0.00 | 242,575 | 531,908 |
| Net Investment Purchase And Sale | -- | 0.00 | 242,575 | 531,908 |
| Investing Cash Flow | -1.9M | 206,011 | -1.7M | -1.1M |
| Cash Flow From Continuing Investing Activities | -1.9M | 206,011 | -1.7M | -1.1M |
| Repayment Of Debt | -72,229 | -284,843 | -227,087 | -161,465 |
| Net Issuance Payments Of Debt | -72,229 | -284,843 | -227,087 | -161,465 |
| Issuance Of Capital Stock | 8.7M | 0.00 | 38.1M | 0.00 |
| Net Common Stock Issuance | 8.7M | 0.00 | 38.1M | 0.00 |
| Financing Cash Flow | 8.6M | 234,473 | 40.3M | 7.9M |
| Cash Flow From Continuing Financing Activities | 8.6M | 234,473 | 40.3M | 7.9M |
| Effect Of Exchange Rate Changes | 244,728 | -203,103 | -2.0M | 1,051 |
| Changes In Cash | -8.0M | -14.3M | 26.7M | -4.2M |
| Beginning Cash Position | 14.0M | 28.4M | 3.7M | 7.9M |
| End Cash Position | 6.2M | 14.0M | 28.4M | 3.7M |
| Free Cash Flow | -16.9M | -15.2M | -13.9M | -12.6M |
| Change In Prepaid Assets | 349,787 | -84,297 | -49,457 | -386,145 |
| Common Stock Issuance | 8.7M | 0.00 | 38.1M | 0.00 |
| Depreciation | 729,668 | 614,704 | 800,864 | 74,799 |
| Gain Loss On Investment Securities | -3.3M | -2.7M | -- | -- |
| Gain Loss On Sale Of PPE | 42,646 | 0.00 | -- | -- |
| Interest Received Cfi | 279,653 | 680,514 | 0.00 | -- |
| Long Term Debt Payments | -72,229 | -284,843 | -227,087 | -161,465 |
| Net Business Purchase And Sale | -- | -- | -- | 0.00 |
| Net Foreign Currency Exchange Gain Loss | -2.1M | 1.3M | -1.5M | 84,040 |
| Net Income From Continuing Operations | -13.4M | -14.0M | -9.9M | -13.3M |
| Net Long Term Debt Issuance | -72,229 | -284,843 | -227,087 | -161,465 |
| Operating Gains Losses | -5.3M | -1.3M | -1.5M | 84,040 |
| Proceeds From Stock Option Exercised | 76.00 | 519,316 | 2.4M | 8.1M |